The Biosecure Immunology Laboratory sits within inside AAHL's physical containment level 3 (PC3) quarantine envelope and houses a flow cytometer machine capable of sorting infected live cell types enabling researchers to compare the immune responses of different animal species, including humans, to highly pathogenic zoonotic agents.
The Werribee Animal Health Facility (WAHF), comprises almost 20 acres of grazing areas, stock yards and animal room accommodation for medium to large animal species requiring QC1 to QC2 levels of microbiological, quarantine approved, containment.
The BMTF aims to provide an environment in which the existing research expertise from partners and collaborators will come together to create critical mass in collaborative multidisciplinary research teams, to develop new materials for devices, diagnostics, delivery technologies, imaging agents and the assessment of these materials through new, non-invasive, in situ imaging techniques.
The MCATS Health Economics Unit undertakes a range of projects focused on economic evaluation as well as the assessment of efficiency, equality and quality of healthcare production and performance. Researchers leverage the data from these projects to inform policy-making decisions at State, Commonwealth and International levels.
We have developed a comprehensive and integrated programme of methodological and collaborative research which is complemented by our statistical training to build a skilled clinical research workforce. Our group also delivers the Master of Biostatistics (with the Biostatistics Collaboration of Australia, BCA), and leads biostatistics teaching within the Master of Public Health and Master of Science (Epidemiology).
We have started a new chapter in the Blood Service story, and are now innovating and growing by extending our infrastructure and capabilities to support the healthcare industry and ultimately deliver improved patient outcomes.
Located at the Monash Institute of Pharmaceutical Sciences, Drug Delivery, Disposition and Dynamics, the HMS Trust Laboratory is a new facility bringing together state of the art equipment for chemical analysis and solid state characterisation.
The University of Melbourne led consortium places emphasis on being engaged with the scientific community to enable appropriate usage of biomedical imaging technologies. It aims to promote collaboration between human preclinical, human clinical and large animal researchers with the common goal of improving health outcomes using ONEHEALTH as the research approach.
To enable and advance research excellence through the provision of a world-class research capability in electron microscopy for the determination of the structure of matter down to the atomic scale.
Development of innovative device solutions for a range of medical disorders, including Parkinson's disease, epilepsy, essential tremor and Obsessive Compulsive Disorder
Sound proof booths for visual psychophysics and functional vision testing in low vision or visual prosthesis (‘bionic eye’) patients
The Bioinformatics Platform is a network of bioinformaticians to support and partner with your research.
BioMation provides a bespoke animation & illustration service to aid visualisation of biomedical processes, molecular structures & cellular interactions. From concept to delivery, BioMation works in collaboration with our clients to create compelling visualisations to inspire their target audiences. BioMation houses a unique combination of scientific and creative expertise.
The Transgenic facility has a proven capability in the creation of transgenic rodent models through ES cell transfection and DNA injection techniques including the use of BAC, YAC and viral transgenesis. The facility is able to provide additional advanced reproductive services including Intracytoplasmic Sperm Injection (ICSI mediated transgenesis) and in vitro fertilisation (IVF) procedures.
Custom designed targeting constructs, conditional knock-outs, knock-ins, reporter lines, point mutations, humanised genes, FLP deleter, CRE deleter transgenic constructs, BAC modifications for multiple organisms (mice, rat, human, primate, zebrafish, axolotl) southern screening strategies including cloning of southern probes. CRISPR technology, genotyping strategies, construct design.
DNA constructs are electroporated in our facility into mouse or rat ES cells. After selection, clones are picked and screened by Southern Blot. The correctly targeted clones are then thawed and expanded and only after re-confirmation by Southern and sequencing, they are injected into blastocysts by the Transgenic Services at Monash.
The Monash Immersive Visualisation Platform features CAVE2(TM) - a world-leading capability for the display and interactive exploration of rich and large datasets. It is used by scientists, engineers and artists to visualise, manipulate and comprehend data such as engineering models, multi-dimensional images across the size scale from nanoscopic to cosmic, and the outputs of scientific, computational and engineering simulations across the physical and life sciences and the arts and humanities.
Featuring a wide range of capabilities in surface modification, thin films, polymer grafting, biomolecule immobilisation and bioactive coatings in polymers, ceramics and metals.
The BOMP provides access to optimal live cell imaging, conventional confocal microscopy, as well as pioneering microscopy 2-photon and super-resolution microscopy instrumentation. We provide a complementary suite of capabilities including PC2 and pathogen handling capabilities, and full access to our expert staff.
The Melbourne Brain Centre Imaging Facility, located at the University of Melbourne's Parkville Campus, hosts state-of-the-art PET/CT and 7 TMRI scanners. The Facility is led by Prof Roger Ordidge and supported by Mr Rob Wiliams (PET/CT) and Dr Brad Moffat. We welcome enquiries regarding your research projects.
Medical Bionics is a multi-disciplinary field of research combining bio(logy) and (electro)nics in order to develop implantable devices designed to provide sensory or motor function following damage to nerve or muscle tissue. The cochlear implant (bionic ear) is the most sophisticated and successful medical bionic device in use today The Bionics Institute Preclinical Trials for Medical Devices provides a service for the testing of medical devices for safety and efficacy.
With over 30 years of experience in development of cochlear implant technologies and translational design into retinal prostheses and neuro bionics fields, the Bionics Institute brings a multidisciplinary approach to custom implant design and fabrication. Specialising in taking designs from sketches to realised prototypes, our facilities and personnel offer a full suite of capabilities including digital design, rapid prototyping, iterative implant fabrication, testing and validation.
Neurobionics is a sector within medical bionics that aims to develop devices designed to monitor, diagnose and treat a variety or neurological disorders including epileptic seizures, drug resistant psychiatric and movement disorders and chronic pain alleviation. The Bionics Institute Clinical Neurobionics Centre brings clinicians and researchers together to conduct innovative patient-focused R & D to develop new neurobionic devices. - www.bionicsinstitute.org
This platform is a combination of atomic force microscopy (AFM), colloidal characterisation equipment and indentation capabilities to provide surface and material characterisation of a broad range of materials to support research activities in engineering, science and medicine. This platform has the capacity to provide information on surface topography, elasticity, magnetic and electrical properties, colloidal forces, wetting properties, and micro- and nano- mechanical material property characterisation.
Two biological isolator facilities have been established to facilitate clinical development of human cell-based therapies. Established under the auspices of the Victorian Consortium for Cell-based Therapies (VCCT), the isolators provide a complete barrier from environmental and operator-borne contamination and are therefore ideally suited for aseptic processing.